Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Rocket Pharmaceuticals, Inc. (RCKT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Rocket Pharmaceuticals, Inc. (RCKT), most recent 12 months reported: revenue $0, net loss $17.25M, free cash flow -$170.39M. Latest balance sheet on file: liquid cash $283.75M. From SEC filings. Others in Pharmaceutical Preparations: Pulmatrix, Inc. · Palvella Therapeutics, Inc. · Quoin Pharmaceuticals Ltd. · Rapport Therapeutics, Inc. · REVELATION BIOSCIENCES, INC. · ROCKET ONE INC. · RELMADA THERAPEUTICS, INC. · TRANSCODE THERAPEUTICS, INC.

Stock screener

Watchlist